BLFS Biolife Solutions Inc

Price (delayed)

$46.69

Market cap

$1.89B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.85

Enterprise value

$1.81B

Highlights
The company's revenue has surged by 56% YoY and by 10% QoQ
The company's gross profit rose by 32% YoY and by 6% QoQ
BLFS's net income has dropped by 155% year-on-year
The EPS has dropped by 152% year-on-year

Key stats

What are the main financial stats of BLFS
Market
Shares outstanding
40.39M
Market cap
$1.89B
Enterprise value
$1.81B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.47
Price to sales (P/S)
29.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
34.26
Earnings
Revenue
$52.77M
EBIT
-$23.59M
EBITDA
-$16.92M
Free cash flow
-$3.2M
Per share
EPS
-$0.85
Free cash flow per share
-$0.1
Book value per share
$6.25
Revenue per share
$1.59
TBVPS
$4.56
Balance sheet
Total assets
$240.02M
Total liabilities
$31.25M
Debt
$11.18M
Equity
$208.78M
Working capital
$100.16M
Liquidity
Debt to equity
0.05
Current ratio
7.11
Quick ratio
6.09
Net debt/EBITDA
4.6
Margins
EBITDA margin
-32.1%
Gross margin
55.2%
Net margin
-38.4%
Operating margin
-11%
Efficiency
Return on assets
-10.3%
Return on equity
-11.5%
Return on invested capital
-60.6%
Return on capital employed
-10.5%
Return on sales
-44.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BLFS stock price

How has the Biolife Solutions stock price performed over time
Intraday
0.54%
1 week
5.23%
1 month
6.11%
1 year
126.98%
YTD
17.05%
QTD
4.9%

Financial performance

How have Biolife Solutions's revenue and profit performed over time
Revenue
$52.77M
Gross profit
$29.14M
Operating income
-$5.78M
Net income
-$20.29M
Gross margin
55.2%
Net margin
-38.4%
BLFS's net income has dropped by 155% year-on-year
The net margin has dropped by 135% year-on-year
The company's revenue has surged by 56% YoY and by 10% QoQ
BLFS's operating income is down by 44% QoQ

Growth

What is Biolife Solutions's growth rate over time

Valuation

What is Biolife Solutions stock price valuation
P/E
N/A
P/B
7.47
P/S
29.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
34.26
The EPS has dropped by 152% year-on-year
BLFS's price to book (P/B) is 41% higher than its last 4 quarters average of 5.3 and 8% higher than its 5-year quarterly average of 6.9
The P/S is 167% higher than the 5-year quarterly average of 11.0 and 52% higher than the last 4 quarters average of 19.4
The company's revenue has surged by 56% YoY and by 10% QoQ

Efficiency

How efficient is Biolife Solutions business performance
The return on sales has dropped by 143% year-on-year
The ROIC has plunged by 128% YoY
Biolife Solutions's return on assets has shrunk by 122% YoY
The ROE has plunged by 118% YoY

Dividends

What is BLFS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BLFS.

Financial health

How did Biolife Solutions financials performed over time
The total assets has soared by 153% YoY and by 2.2% QoQ
The total liabilities has increased by 15% YoY and by 6% from the previous quarter
The debt is 95% smaller than the equity
Biolife Solutions's debt to equity has soared by 150% YoY
The debt has grown by 13% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.